Home/ Stocks/ KOD

Kodiak Sciences Inc Common Stock

KOD XNAS

$21.85 -0.39 (-1.75%) ▼ 15-min delayed

Open

$21.84

High

$22.14

Low

$21.00

Volume

501.6K

Market Cap

$1.36B

About Kodiak Sciences Inc Common Stock

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 121 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-61,457,000	$-1.16
Q1 2025	$0	$-57,461,000	$-1.09
FY 2024	$0	$-176,207,000	$-3.35
Q3 2024	$0	$-43,946,000	$-0.84

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for KOD yet. Check out our latest market news or earnings calendar.

Get KOD Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Kodiak Sciences Inc Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.